Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04376333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Individualized Assessment and Treatment for TMD

Study acronym: TMD3c
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Site details revised
    v13
  2. Trial status changed: Active, Not Recruiting → Recruiting
    • Site details revised
    v12
  3. Trial status: Suspended to Active, Not Recruiting
    • Primary completion date: Nov 30, 2025 to Mar 31, 2027
    • Study completion date: Jun 1, 2026 to Jun 30, 2027
    v11
  4. Trial status: Recruiting to Suspended Sponsor's reason: Funding interrupted
    • Primary completion date: Jan 31, 2025 to Nov 30, 2025
    • Site details revised
    v10
  5. Re-verified, no change to tracked fieldsv9
Show 7 earlier versionsHide 7 earlier versions
  1. Eligibility criteria expanded, about 2 wordsv8
  2. Re-verified, no change to tracked fieldsv7
  3. Start date: Feb 11, 2020 to Feb 3, 2021v6
  4. Start date: Dec 1, 2020 to Feb 11, 2020v5
  5. Re-verified, no change to tracked fieldsv4
  6. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  7. Start date: Sep 1, 2020 to Dec 1, 2020v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
Temporomandibular/orofacial pain disorders (TMD) are a group of painful conditions with multiple determinants.This proposal has two main goals: 1) to test a highly individualized, adaptive treatment for TMD that has potential to be more effective than other psychosocial treatments; and 2) to discover the mechanisms by which psychosocial treatments work in chronic pain. TMD patients (N=160) will be randomized to receive standard care (STD) + an individualized assessment and treatment program (IATP) or to standard care + conventional cognitive-behavioral treatment (STD+CBT). It is expected that the STD+IATP treatment will yield lower pain, depression and interference scores over time than STD+CBT, and that changes in coping ability will mediate the treatment effects on outcomes.
Trial Details
NCT Number NCT04376333
Lead Sponsor UConn Health
Collaborators: National Institute of Dental and Craniofacial Research (NIDCR)
Conditions
(from sponsor)		 Temporomandibular Joint Disorders, Orofacial Pain
Related terms Chronic Pain, Facial Pain, Temporomandibular Joint Disorders
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov